References
- Ahnn, S., Anderson, S.J. (1995). Sample size determination for comparing more than two survival distributions. Statist. Med. 14:2273–2282.
- Ahnn, S., Anderson, S.J. (1998). Sample size determination in complex clinical trials comparing more than two groups for survival endpoints. Statist. Med. 17:2525–2534.
- Bernstein, D., Lagakos, S.W. (1978). Sample size and power determination for stratified clinical trials. J. Statist. Computat. Simul. 8:65–73.
- Breslow, N., Haug, C. (1972). Sequential comparison of exponential survival curves. J. Amer. Statist. Assoc. 67:691–697.
- Collett, D. (2003). Modeling Survival Data in Medical Research. London: Chapman and Hall.
- Dunnett, C.W. (1955). A multiple comparison procedure for comparing several treatments with a control. J. Amer. Statist. Assoc. 50:1096–1121.
- Finney, D.J. (1952). Statistical Methods in Biological Assay. New york: Hafner Publishing Company.
- Fleiss, J.L. (1986). Design and Analysis of Clinical Experiments. New york: John Wiley & Sons, Inc.
- Friedman, L.M., Furberg, C.D., Demets, D.L. (2010). Fundamentals of Clinical Trials. New York: Springer.
- George, S.L., Desu, M.M. (1974). Planning the size and duration of a clinical trial studying the time to some critical event. J. Chron. Dis. 27:15–24.
- Halabi, S., Singh, B. (2004). Sample size determination for comparing several survival curves with unequal allocation. Statist. Med. 23:1793–1815.
- Heo, M., Faith, M.S., Allison, D.B. (1998). Power and sample size for survival analysis under the weibull distribution when the whole lifespan is of interest. Mechan. Ageing Develop. 102:45–53.
- Hinkley D.V. (1975). On power transformations to symmetry. Biometrika 62:101–111.
- Hosmer, D.W., Lemeshow, S. May, S. (2008). Applied Survival Analysis. New york: John Wiley & Sons.
- Julious, S.A. (2010). Sample Sizes for Clinical Trials. New york: CRC Press.
- Jung, S., Hui, S. (2002). Sample size calculation for rank tests comparing K survival distributions. Lifetime Data Anal. 8:361–373.
- Lawless, J.F. (1982). Statistical Models and Methods for Lifetime Data. New york: John Wiley & Sons.
- Liu, P.Y., Dahlberg, S. (1995). Design and analysis of multiarm clinical trials with survival endpoints. Control. Clin. Trials 16:119–130.
- Liu, S., Tu, D. (2008). On the applications of Fisher's least significant difference (LSD) procedure in three-arm clinical trials with survivor endpoints. Drug Info. J. 42: 81–91.
- Lustbader, E.D., Litwin, S. (1981). Design of censored survival studies. Biometrics 37:697–704.
- Marschner, I.C. (2007). Optimal design of clinical trials comparing several treatments with a control. Pharmaceut. Statist. 6:23–33.
- Makuch, R.W., Simon, R.M. (1982). Sample size requirements for comparing time-to-failure among k treatment groups. J. Chron. Dis. 35:861–867.
- Marschner, I.C. (2007). Optimal design of clinical trials comparing several treatments with a control. Pharmaceut. Statist. 6:23–33.
- Schoenfeld, D. (1981). The asymptotic properties of nonparametric tests for comparing survival distributions. Biometrika 68:316–319.
- Schoenfeld, D. (1983). Sample-size formula for the proportional-hazards regression model. Biometrics 39:499–503.
- Spindler, S.R., Mote, P.L. (2007). Screening candidate longevity therapeutics using gene-expression arrays. Gerontology 53:306–321.